毒理学杂志

[1] Khanam H, Ali A, Asif M, et al. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review[J]. Eur J Med Chem, 2016, 124: 1121-1141.

[2] Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases[J].Acta Neuropathol, 2017, 134(2): 187-205.

[3] Alzheimer′s Association. 2015 Alzheimer′s disease facts and figures[J]. Alzheimers Dement, 2015,11(3): 332-384.

[4] Siegel RL, Miller KD, Jemal A. Cancer statistics,2018[J]. 2018, 68(1): 7-30.

[5] Munoz DG, Feldman H. Causes of Alzheimer′s disease[J]. CMAJ, 2000, 162(1): 65-72.

[6] Tanzi RE. The genetics of Alzheimer disease[J].Cold Spring HarbPerspect Med,2012, 2(10): a006296.

[7] Stocchi F, Rabey JM. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson′s disease[J]. Eur J Neurol, 2011, 18(12): 1373-1378.

[8] 杨辉, 左伋, 刘雯. Parkin、PINK1、DJ-1 和线粒体功能障碍与帕金森病[J]. 生命科学, 2010,22(10): 1009-1012.

[9] 朱姝,唐铁山.DNA损伤修复与亨廷顿病的发生机制[J].生物化学与生物物理进展,2017,44(9):727-736.

[10] Goold R, Flower M, Moss DH, et al. FAN1 modifies Huntington′s disease progression by stabilising the expanded HTT CAG repeat[J]. Hum Mol Genet, 2018. [Epub ahead of print]

[11] Lim J, Yue Z. Neuronal aggregates: formation, clearance, and spreading[J]. Dev Cell, 2015, 32(4): 491-501.

[12] 任梦丹. A53T突变对α-synuclein错误折叠和聚集影响的分子模拟研究[D].兰州:兰州大学,2017.

[13] Kumar V, Sami N, Kashav T, et al. Protein aggregation and neurodegenerative diseases: From theory to therapy[J]. Eur J Med Chem, 2016, 124: 1105-1120.

[14] Wolozin B. Regulated protein aggregation: stress granules and neurodegeneration[J]. Mol Neurodegener, 2012, 7: 56.

[15] Bandyopadhyay U, Cuervo AM. Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein[J]. Exp Gerontol, 2007, 42(1-2): 120-128.

[16] Selkoe DJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer′s disease[J]. Trends Cell Biol, 1998, 8(11): 447-453.

[17] Lorenzen N, Nielsen SB, Yoshimura Y, et al. How epigallocatechin gallate can inhibit alpha-synuclein oligomer toxicity in vitro[J]. J Biol Chem, 2014, 289(31): 21299-21310.

[18] Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson′s disease[J]. Cell, 2016, 167(6): 1469-1480.e12.

[19] Kumar V, Gill KD. Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review[J]. Neurotoxicology, 2014, 41: 154-166.

[20] Valko M, Jomova K, Rhodes CJ, et al. Redox-and non-redox-metal-induced formation of free radicals and their role in human disease[J]. Arch Toxicol, 2016, 90(1): 1-37.

[21] Mohsenzadegan M,Mirshafiey A. The immunopathogenic role of reactive oxygen species in Alzheimer disease[J].Iran J Allergy Asthma Immunol,2012,11(3):203-216.

[22] Xu J, Wang K, Yuan Y, et al. A novel peroxidase mimics and ameliorates Alzheimer′s Disease-related pathology and cognitive decline in mice[J]. Int J Mol Sci, 2018, 19(11): E3304.

[23] 彭天婵,李清华.线粒体功能障碍与帕金森病的研究进展[J].华夏医学,2016,29(6):155-159.

[24] Mita Y, Kataoka Y, Saito Y. Distribution of oxidized DJ-1 in Parkinson′s disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin[J]. Sci Rep, 2018, 8(1): 12056.

[25] Costa V, Scorrano L. Shaping the role of mitochondria in the pathogenesis of Huntington′s disease[J]. EMBO J, 2012, 31(8):1853-1864.

[26] 崔蔚,陈波,蒋伟,等.亨廷顿病模型小鼠脂质代谢和氧化应激特点[J].中国老年学杂志,2017,37(23):5790-5792.

[27] Woimant F, Trocello JM. Disorders of heavy metals[J]. Handb Clin Neurol, 2014,120: 851-864.

[28] Li Y, Jiao Q, Xu H, et al. Biometal dyshomeostasis and toxic metal accumulations in the development of Alzheimer′s disease[J]. Front Mol Neurosci, 2017, 10: 339.

[29] Sabayan B,Namazi MR,Mowla A,et al.Are patients with Darier and Haily-Haily diseases susceptible to Alzheimer’s disease? A theory based on abnormal intraneuronal Ca2+ homeostasis[J].J Alzheimers Dis,2009, 16(3):521-523.

[30] Braidy N, Poljak A, Marjo C, et al. Metal and complementary molecular bioimaging in Alzheimer′s disease[J]. Front Aging Neurosci, 2014, 6: 138.

[31] Singh N, Haldar S, Tripathi AK, et al. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson′s disease[J]. Antioxid Redox Signal, 2014, 21(3): 471-484.

[32] Wegrzynowicz M, Holt HK, Friedman DB, et al. Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese[J]. J Proteome Res, 2012, 11(2): 1118-1132.

[33] Hands SL, Mason R, Sajjad MU, et al. Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington′s disease[J]. Biochem Soc Trans, 2010, 38(2): 552-558.

[34] 肖桂然. 以果蝇为模型研究铜对亨廷顿舞蹈症的影响机制[D].北京:清华大学,2015.

[35] Ross CA, Truant R. DNA repair: A unifying mechanism in neurodegeneration[J]. Nature, 2017, 541(7635): 34-35.

[36] Madabhushi R, Pan L, Tsai LH. DNA damage and its links to neurodegeneration[J]. Neuron, 2014, 83(2): 266-282.

[37] Madabhushi R, Gao F, Pfenning AR, et al. Activity-induced DNA breaks governthe expression of neuronal early-response genes[J]. Cell, 2015, 161(7): 1592-1605.

[38] Suberbielle E, Djukic B, Evans M, et al. DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice[J]. Nat Commun, 2015, 6: 8897.

[39] 刘红梅. DNA剪切修复对MPTP/MPP+致帕金森病模型DNA氧化损伤的作用研究[D].上海:复旦大学,2009.

[40] Maiuri T, Mocle AJ, Hung CL, et al. Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex[J]. Hum Mol Genet, 2017, 26(2): 395-406.

[41] 廖冬燕. PNS对SAMP8小鼠脑内Aβ沉淀及记忆相关信号通路的影响[D].广州:广州中医药大学,2015.

[42] Gao Y, Liu EJ, Wang WJ, et al. Microglia CREB-phosphorylation mediates amyloid-beta-induced neuronal toxicity[J]. J Alzheimers Dis, 2018, 66(1): 333-345.

[43] Xu Y, Yan J, Zhou P, et al. Neurotransmitter receptors and cognitive dysfunction in Alzheimer‘s disease and Parkinson’s disease[J]. Prog Neurobiol, 2012, 97(1): 1-13.

[44] Choi YS, Lee B, Cho HY, et al. CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington′s disease[J]. Neurobiol Dis, 2009, 36(2): 259-268.

[45] Mancuso M, Coppede F, Migliore L, et al. Mitochondrial dysfunction, oxidative stress and neurodegeneration[J]. J Alzheimers Dis, 2006, 10(1): 59-73.

[46] 方永奇,莫镇涛.脑能量代谢调节机制研究新进展[J].广州中医药大学学报,2011,28(3):328-331.

[47] Yin F, Sancheti H, Patil I, et al. Energy metabolism and inflammation in brain aging and Alzheimer′s disease[J]. Free Radic Biol Med, 2016, 100: 108-122.

[48] Jolivet R, Coggan JS, Allaman I, et al. Multi-timescale modeling of activity-dependent metabolic coupling in the neuron-glia-vasculature ensemble[J]. PLoS Comput Biol, 2015, 11(2): e1004036.

[49] Yin F, Sancheti H, Liu Z, et al. Mitochondrial function in ageing: coordination with signalling and transcriptional pathways[J]. J Physiol, 2016, 594(8): 2025-2042.

[50] Dragicevic N, Mamcarz M, Zhu Y, et al. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer′s transgenic mice[J]. J Alzheimers Dis, 2010, 20(Suppl 2): S535-550.

[51] 张荫杰. 基于脑能量代谢的通络醒脑泡腾片治疗阿尔茨海默病的代谢组学研究[D].成都:成都中医药大学,2014.

[52] Goncalves DF, Courtes AA, Hartmann DD, et al. 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat[J]. Neurotoxicology, 2018. [Epub ahead of print]

[53] Ayala-Peňa S. Role of oxidative DNA damage in mitochondrial dysfunction and Huntington′s disease pathogenesis[J]. Free Radic Biol Med, 2013, 62: 102-110.

[54] Boucher D, Monteleone M, Coll RC, et al. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity[J].J Exp Med, 2018, 215(3):827-840.

[55] Nixon RA. The role of autophagy in neurodegenerative disease[J]. Nat Med, 2013, 19(8): 983-997.

[56] Jiang T, Li G, Xu J, et al. The Challenge of the pathogenesis of Parkinson′s disease: Is autoimmunity the culprit?[J]. Front Immunol, 2018, 9: 2047.

[57] Nussbaum JM,Seward ME,Bloom GS. Alzheimer disease:a tale of two prions[J].Prion,2013,7(1):14-19.